*Parts of the work were presented at the 7th Meeting ofCytokine and Neopterin held on July 22, in Osaka, Japan.
Introduction
Neopterin is synthesized mainly by monocytes/macrophages, so it is considered to be a marker for activation of the cellular immune system (I). Cerebrospinal fluid (CSF) neopterin levels are reported to be useful in the analysis of pathophysical mechanisms in various kinds of central nervous system (eNS) diseases such as CNS infection (2) , erythrophagocytic disorders (3), AIDS (4, 5) , or others (6) (7) (8) (9) . We have demonstrated that CSF neopterin levels are significantly higher in patients with bacterial meningitis than in those with aseptic meningitis or non-pleocytotic CSF (10) .
In this study we measured CSF neopterin levels in patients with pyrexia and/or convulsions to investigate immune conditions in patients with febrile convulsions (FCs) . CSF interferon-gamma (IFN-y), tumor necrosis factor-alpha (TNF-a), and interleukin-l alpha (IL-lo:) were also measured in some patients of each group.
Patients and Methods
Fifty-two patients (32 males and 20 females) were studied (Table I) . CSF and sera were collected from patients attending Nippon Medical School 2nd Hospital or Tama Nagayama Hospital from Sep. l991 to Dec.1998 for spinal tap under suspected diagnosis tum suffered convulsions within 10 minutes (ordinary FCs). EEG was performed in every patient with FCs later and no abnormal fmdings were noted. None of them suffered non-FCs (epileptic seizures) afterwards. Twenty-five patients (16 males and 9 females, day 6-41 /3 years) had pyrexia but not convulsions. Four were diagnosed with exanthem subitum and two Kawasaki disease. Twelve (7 males and 5 females, Ii6_6 1 !2 years) had convulsions without high fever. Eight had epilepsy (including two status epilepticus), two rotavirus infection, one obstructions of the bilateral cerebral arteries (etiology unknown) and pertussis. Informed consent was obtained prior to each examination.
Neopterin was measured in CSF and sera for all patients by the high performance liquid chromatography (HPLC) method (11) . IFN-y levels were deter- Table 2 , the CSF neopterin levels in patients with FCs (n=15) \\'ere 27. 4±33 .0 nmolll and the CSF neopterin serum neopterin ratio (CIS ratio) in patients \'vith Fes \\'as 2.07:::2.06. As long as in patients with ordinary FCs (n=ll), the levels were 12.7±5.3 nmo l!l and 1.21=0.91. CSF neopterin levels in patients with prolonged FCs were 131, 63 , 52 , 25 nmol!L, and the CI S ratio in patients with prolonged FCs was 8.2, 3 .0, 4.0, 3.1 , respectively. CSF neopterin and CIS ratio in patients with prolonged FCs clearl y tended to be at higher levels than in those with ordinary FCs.
Results

Neopterin in patients with l1on-pleoc.vtoric CSF As summarized in
The CSF neopterin levels in patients with pyrexia 
Correlation between CSF neopterin and cytokines in patients with non-pleocytotic CSF
CSF cytokines (IFN-y,TNF-o.,and IL-lo.) were measured in 16 patients (6 patients with FCs, 5 with pyrexia without convulsions, and 5 with convulsions without pyrexia). CSF IFN-y in patients with FCs tended to be at higher levels than in those with only pyrexia or in those with only convulsions. However, the level of CSF IFN-y in the patient with the most severe clinical manifestation of FCs (Patient No.3 in Table 3 ) with an extremely high level ofCSF neopterin for FCs was not high (Table 3) . In every non-pleocytotic CSF sample, TNF-a was under the measurable level of 5 pg/rnl, and IL-l a was also under the measurable level of 7.8 pg/ml.
CSF and serum neopterin in patients with exanthem subitum
Three patients with exanthem subitum had accomPtcridinesiVol. IllNo. 4 panying FCs, and four did not. There was no difference in the serum neopterin levels between patients with exanthem subitum with FCs and those without FCs . However, the CSF neopterin levels in patients \vith exanthem subitum with FCs were clearly higher than in those without FCs (Table 4) . 
Discussion
Numerous studies have been reported previous ly concerning CSF neopterin in connection with various diseases. But there have been almost no report describing the correlation between CSF neopterin levels and convulsive diseases. In this study we have shown that CSF neopterin levels are higher in patients with F Cs than in those with only pyrexia or in those with only convulsions. It has been well-established that pleoc y-totic CSF has a high level of neopterin (2,10). However, of interest even in patients with FCs, whose CSF is not pleocytotic, their CSF has higher levels of neopterin than those with only pyrexia or those with only convulsions. Since it has been reported that relatively higher values in CSF as compared with serum reveal the main focus of impairment as the CNS (15), the results of this study may suggest that an immune response in the CNS of patients with FCs is activated. The results that patients with FCs with higher CSF neopterin levels tended to have longer-lasting convulsions ( Table 2 ), and that CSF neopterin levels in patients with exanthem subitum accompanying FCs were higher than in those without FCs even though there was no difference in the serum neopterin levels (Table 4) , seemed to indicate such immune activation in the CNS.
Neopterin is said to be produced by activated monocytes/macrophages (1) or endothelial cells (16) under stimulation by IFN-y. Identification of the origin of macrophages and microglial cells (17, 18) and the possibility of neopterin production by microglial cells (19) have been reported. Our finding that CSF neopterin levels were elevated in patients with FCs, whose CSF had no pleocytosis also seems not to conflict with the possibility of neopterin production by microglia.
Some CSF cytokines were also measured at the same time. As for TNF-a and IL-la, the result that their levels in CSF from patients with pyrexia and/or convulsions are under measurable limits reveals that they are not concerned in the mechanism of FCs. The patients with FCs tended to have higher levels of CSF IFN-y than those with only pyrexia or convulsions. On the other hand, CSF IFN-y levels in patients with FCs did not always seem to depend on the severity or duration of the convulsions. Indeed, in spite of an extremly high level of CSF neopterin in patients with FCs, the most severe patient had quite a low level of CSF IFNy. This may suggest that IFN-y is not the only factor of the macrophage/microglial cell activation resulting in neopterin production (20, 21) . We hypothesize that the induction of exceedingly severe convulsions breaks the system of IFN-y production in the CNS, but some other system(s) of neopterin production may be at work under the cytokine networks . Furthermore, even though patients had severe convulsions such as status epilepticus, CSF neopterin or IFN-y in those with nonFCs did not increase (Table 3) . Therefore, we can assume that some kind(s) of immune activation in the CNS resulting in the elevation of CSF neopterin may be associated with the pathophysiology of FCs, but not non-FCs.
Some investigators suggest that microglia themselves produce cytokines (17, 19) or release cytotoxic substances under activation (18), thus we should presume that pathophysiology of the immune state in the CNS is very complicated.
As for the exanthem subitum, it has been demonstrated that human herpesvirus 6 (HHV -6) invades the brain during the acute phase of the disease, and recurrence ofFCs may be associated with the reactivation of HHV-6 by PCR technique (22) .
This study suggests the possibility that immune activation of microgrial cells is one of the mechanisms involved in the onset ofFCs, in addition to the regional GABA concentration in subcortical structures in model animals reported previously (23) .
